Koninklijke Philips N.V. (XETRA: PHI1.DE) Stock Competitors & Peer Comparison
See PHI1.DE's competitors and their performance on the XETRA and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PHI1.DE and its XETRA peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHI1.DE | €23.61 | -0.46% | 23.1B | 18.56 | €1.27 | +3.60% |
| ABL.DE | €99.36 | +0.93% | 171.9B | 25.96 | €3.83 | +2.12% |
| SYK.DE | €282.25 | +0.61% | 108.2B | 30.03 | €9.40 | +1.06% |
| 2M6.DE | €79.66 | -0.75% | 102B | 16.77 | €4.75 | +3.06% |
| SHL.DE | €40.20 | +0.98% | 45B | 17.12 | €2.35 | +2.49% |
| DRW3.DE | €110.80 | +0.36% | 2.1B | 12.16 | €9.11 | +2.05% |
| DRW8.DE | €82.20 | +0.74% | 2B | 9.04 | €9.09 | +2.05% |
| SBS.DE | €21.65 | +0.23% | 263.2M | 30.69 | €0.71 | +2.77% |
| GME.DE | €2.59 | -2.26% | 14M | 4.11 | €0.63 | +3.86% |
| E8X.DE | €0.14 | +1.45% | 1.5M | -1.08 | -€0.13 | N/A |
Stock Comparison
Abbott Laboratories (XETRA: ABL.DE)
PHI1.DE vs ABL.DE Comparison August 2026
Koninklijke Philips N.V. (XETRA: PHI1.DE) plays a significant role within the Healthcare sector. Its performance on the XETRA reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHI1.DE stands at 23.1B. In comparison, ABL.DE has a market cap of 171.9B. Regarding current trading prices, PHI1.DE is priced at €23.61 on the XETRA, while ABL.DE trades at €99.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHI1.DE currently has a P/E ratio of 18.56, whereas ABL.DE's P/E ratio is 25.96. In terms of profitability, PHI1.DE's ROE is +0.10%, compared to ABL.DE's ROE of +0.11%. Regarding short-term risk, PHI1.DE is less volatile compared to ABL.DE. This indicates lower risk in terms of short-term price fluctuations for PHI1.DE.Check ABL.DE's competition here